Aptus Pharma Limited (BOM:544529)

India flag India · Delayed Price · Currency is INR
285.30
+13.55 (4.99%)
At close: Mar 9, 2026
253.09%
Market Cap 1.96B
Revenue (ttm) 291.80M
Net Income (ttm) 35.41M
Shares Out 6.86M
EPS (ttm) 5.04
PE Ratio 56.61
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,000
Average Volume 7,000
Open 285.30
Previous Close 271.75
Day's Range 276.00 - 285.30
52-Week Range 80.80 - 285.30
Beta n/a
RSI 73.34
Earnings Date Feb 10, 2026

About Aptus Pharma

Aptus Pharma Limited engages in the marketing and distribution of finished pharmaceutical formulations. The company operates through four divisions: Aptus Pharma, Pioneer division which includes marketing of acute therapies including general anti-infectives, pain management, antacids, and gastrointestinal drugs; Aptus CD Care, Cardiac Diabetic division which includes marketing of chronic therapies, including anti-hypertensive, anti-diabetic, and lipid-lowering; Aptus Wellcare offers wellness and nutraceutical products, over-the-counter (OTC) fo... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 2010
Employees 70
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544529
Full Company Profile

Financial Performance

In fiscal year 2025, Aptus Pharma's revenue was 245.58 million, an increase of 37.52% compared to the previous year's 178.57 million. Earnings were 31.00 million, an increase of 260.45%.

Financial Statements

News

There is no news available yet.